Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma

doi:10.4251/wjgo.v16.i6.2380

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (522)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

HTML

340

Figures (1-6)

Tables (1-2)

Sum=456

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=52

Jun 15, 2024 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2380-2393
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2380

Table 1 Biomarkers for predicting hepatic artery infusion chemotherapy prognosis

Biomarker	PFS HR (95%CI)	OS HR (95%CI)	ORR HR (95%CI)	ORR (%)	Ref.
NLR	1.363 (1.008-1.843)	1.492 (1.106-2.012)	1.918 (1.092-3.369)	37.6	[31]
NLR	1.984 (1.111-3.545)			24.3	[39]
DCP	2.460 (1.434-4.220)	3.097 (1.728-5.551)		24.3	[39]
AFP DCP		2.17 (1.23-3.92)		51.9	[52]
AFP DCP		1.9 (1.06-3.42)		56.4	[52]
VEGF		2.42 (1.33-4.38)		35.2	[43]
Serum transferrin		1 (0.132-0.603)		46.9	[47]
IL-28B		1.720 (1.072-2.759)	2.620(1.124-6.107)	51.9	[73]

NLR: Neutrophil to lymphocyte ratio; DCP: Des-γ-carboxy prothrombin; AFP: Alpha-fetoprotein; VEGF: Vascular endothelial growth factor; IL-28B: Interleukin-28B; PFS: Progression-free survival; OS: Overall survival; ORR: objective response rate; CI: Confidence interval.

Citation: Wang QF, Li ZW, Zhou HF, Zhu KZ, Wang YJ, Wang YQ, Zhang YW. Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2380-2393
URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2380.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2380